Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Root, Inc. to Participate in the 28th Annual ICR Conference
-
Teladoc Health to Participate in Upcoming Investor Conference
-
Fitell Corporation Announces Share Consolidation
-
Ingersoll Rand Expands Life Sciences Capabilities with Acquisition of Scinomix, Inc.
-
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
REV Exploration Announces Upsizing of Life Offering
-
Quantum Capital Group Announces Sale of Cogentrix to Vistra for $4.7 Billion
-
Digital Ally Announces Name Change To Kustom Entertainment, Inc., Ticker Symbol Change To “KUST” Reflecting Strategic Pivot To Live Events And Online Ticketing Markets, and Reverse Stock Split
-
Mobix Labs, Inc. Announces Proposed Public Offering of Common Stock
-
Jefferson Capital Announces Launch of Secondary Public Offering and Concurrent Share Repurchase
-
Microchip Technology Provides Q3 Fiscal 2026 Business Update
-
Onity Group Announces Appointment of Dawn Morris to Board of Directors
-
Lands' End Announces Participation in the 28th Annual ICR Conference
-
Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Occidental to Announce Fourth Quarter Results Wednesday, February 18, 2026; Hold Conference Call Thursday, February 19, 2026
-
GAMCO Expects to Report Diluted EPS for the Fourth Quarter 2025 of $0.67 to $0.73 Per Share and 2025 Diluted EPS of $3.09 to $3.15 Per Share
-
Enovis Appoints Oliver Engert as Chief Administrative Officer
-
Lands' End Announces Participation in the 28th Annual ICR Conference
-
FinWise Bancorp to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on Thursday, January 29, 2026
-
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
YES Communities Announces Retirement of COO Karen Hamilton; Julie Bowlen Appointed to Role
-
KALA BIO Settles Approximately $10.6 million of Debt
-
3D Systems to Present at the Needham Growth Conference
-
Compass Diversified Declares Fourth Quarter 2025 Distributions on Series A, B and C Preferred Shares
-
AVITA Medical Announces Changes to its Board of Directors
-
The Joint Corp. Appoints Ron Stilwell SVP Operations and Patient Experience
-
Revolution Medicines to Present at 44th Annual J.P. Morgan Healthcare Conference
-
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
-
First Watch Restaurant Group, Inc. to Participate in the 28th Annual ICR Conference
-
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
-
Zscaler Appoints Sunil Frida as Chief Marketing Officer to Drive Next Phase of Global Growth
-
Great Southern Bancorp, Inc. Announces Fourth Quarter 2025 Preliminary Earnings Release Date and Conference Call
-
Covenant Logistics Group, Inc. Announces Timing of Fourth Quarter Earnings Release and Conference Call
-
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Bel Fuse Announces Participation in the 28th Annual Needham Growth Conference
-
Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was to Participate in the ICR Conference 2026
-
The Lovesac Company Announces Participation in the 2026 ICR Conference
-
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
HF Foods to Participate in the ICR Conference
-
Concrete Pumping Holdings Sets Fourth Quarter and Fiscal Year 2025 Earnings Conference Call for Tuesday, January 13, 2026
-
Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
TEN Ltd. Declares Dividend on its Series F Cumulative Redeemable Perpetual Preferred Shares
-
Silvaco To Present at the 28th Annual Needham Growth Conference
-
Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
-
Evolution Metals & Technologies Corp. Consummates Business Combination Prior to Trading on NASDAQ
-
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Evolution Metals & Technologies Corp. Consummates Business Combination Prior to Trading on NASDAQ
-
Osisko Metals Appoints COO
-
Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression
